Prognostic value of fetoplacental function tests: a review 1
Professor Peter Curzen MD FRCOG Obstetric Unit, Westminster Medical School, Queen Mary's Hospital, Roehampton, London SW15 5PN The placenta is the life-support system of the fetus and has two functions: transport and synthesis. Its villous structure provides an enormous surface area for bringing the fetal circulation via the capillaries of the villi into close relationship with the maternal circulation of the intervillous or choriodecidual space. During normal pregnancy at term, the mean maternal blood flow through the intervillous space is 600 ml per minute (Browne & Veall 1953) , and at the functional level of the terminal villi the maternal blood is separated from the fetal blood by only the endothelium of the villous capillaries juxtaposed to the very attenuated syncytiotrophoblast. In certain complications of pregnancy, principally those associated with hypertension and postmaturity, placental function may become impaired. In the hypertensive disorders of pregnancy this is due to pathological narrowing of the spiral arterioles which supply the intervillous space (Robertson et al. 1967) and may result in reduced placental perfusion by maternal blood. In postmaturity the reason for impaired placental function is less clear, but it may be related to intrinsic ageing changes in the placenta. When there is impaired placental function, the main clinical consequences are due to interference with transport of substances between the maternal and fetal circulations. Reduced active transport of amino acids will tend to occur first when there is chronic placental insufficiency, and will be associated with intrauterine growth retardation of the fetus. The baby is born dysmature, which means not only that it is too small in relation to weight distribution curves standardized for parity, gestation age, and sex of the infant, but also that it shows functional signs of inadequate development. These babies are at increased risk during the neonatal period and have also been shown to remain at a disadvantage into childhood, being less well developed both physically and intellectually when compared with preterm babies whose birth weights fell into the normal range for gestation age (Neligan et al. 1976) . Reduced passive transport of oxygen occurs when there is acute placental insufficiency, either as an end stage of the chronic form, or when it arises de novo in relation to severe hypertension of sudden onset, or when there has been an abruptio placentae. The resulting fetal hypoxia commonly presents as fetal distress in labour but may cause the death of the fetus then, or during pregnancy. Fetal hypoxia and dysmaturity remain among the most important causes not only of perinatal mortality and morbidity but also of subsequent abnormal development during childhood. Since they are commonly but not exclusively the result of impaired placental transport, the early recognition of what is still rather loosely termed 'placental insufficiency' continues to be one of the main objectives of antenatal care. However, since the main concern is with fetal prognosis, the aims should be to diagnose intrauterine growth retardation in order to predict the risk of dysmaturity, and to accurately predict the fetus which will be at risk from fetal distress in labour or from intrauterine death due to hypoxia.
The routine clinical screening procedures performed during pregnancy will identify many but not all those women whose fetuses are at risk from hypoxia or dysmaturity. Moreover, these clinical screening procedures will identify some pregnancies as being at risk, although the fetal outcome turns out to be entirely normal. Some of the important features associated with increased fetal risk are: maternal age, with increased risk at both extremes of the reproductive epoch; low socioeconomic class of the mother; a previous pregnancy which resulted in a stillborn or dysmature baby; heavy smoking during pregnancy; any form of hypertension ; and abnormal weight gain. Elder et al. (1970) showed that normal pregnancy in which there was a progressive weight loss of more than 500 grams between two successive antenatal clinical visits, or failure to gain weight over three successive clinic visits during the third trimester, was associated with a 15.1% incidence and a 15.9% incidence respectively oflight-for-dates infants; whereas in pregnancies where the weight gain in the third trimester was normal, the incidence of dysmature babies was only 5.1%. While these figures show that the abnormal weight gain criteria used are associated with an approximately trebled risk of dysmaturity, they also illustrate their poor predictive value with incidences of about 84% false positives and 5.1% false negatives. In order to improve the ability to accurately predict which pregnancies will be complicated by fetal hypoxia or dysmaturity, various biochemical assays and special physical monitoring methods have been introduced.
Urinary oestriol
The 24-hour urinary output of oestriol has been used for the last 20 years as a prognostic index during pregnancy. Unlike other hormones which are produced in large amounts during pregnancy, oestriol is unique in that its synthesis is dependent on the fetus and placenta working together as a single endocrine unit (Diczfalusy & Mancuso 1969) . As a result it is perhaps not surprising that the 24-hour production of oestriol should be partly dependent on the condition of the fetus in general, and its size in particular. There have been numerous publications reporting the usefulness of 24-hour urinary oestriol assays, which have been reviewed by Klopper (1968) and Turnbull (1970) . The interpretation of the results has been based on whether they fall above the lower limit of the normal range which some workers have taken as the mean minus two standard deviations while others have used the 10th percentile, and on whether the serial profile shows a progressive increase which is interpreted as normal, or a progressive decrease which is interpreted as abnormal. There is general agreement that oestriol assays have to be performed serially if they are to be useful and that when fetal growth is retarded, oestriol excretion is depressed in approximately 90% of cases. However, an abnormally low oestriol output is not so useful in predicting fetal distress. Beischer et al. (1968) measured the oestriol output in 597 patients; in 90 patients with a low output, 47% developed an abnormality of fetal heart rate in labour, i.e. there were 53 per cent false positives; while in 507 patients with a normal oestriol excretion, 12% developed fetal heart rate abnormalities in labour. Fliegner et al. (1969) studied 80 high risk pregnancies; in 24 with abnormally low oestriol excretion, 42% developed fetal acidosis in labour as indicated by a fetal scalp blood sample with a pH ofless than 7.2, i.e. there were 58% false positives. In 56 patients with normal oestriol output, 7% developed fetal acidosis in labour (false negatives).
Plasma oestriol
The obvious disadvantage of the 24-hour urinary oestriol assay, apart from the potentially misleading results which may follow incomplete collections, is the inevitable 24-hour delay in getting the result. With the advent of sensitive and specific radioimmunoassays for oestriol, the measurement of this hormone in plasma seemed to offer a better alternative. However, there are several oestriol fractions in the plasma, including free oestriol, oestriol glucosiduronate and oestriol sulphate. It is still not clear which of these, if any, is likely to be most useful, or whether the total oestriol should be assayed. Klopper et al. (1975) tried to resolve this problem by determining the day-to-day variability of total and unconjugated plasma oestriol in the same subject, and found coefficients of variation of 13.2% and 30.9% respectively. However, a similar study from the same department (Klopper et al. 1977) reported coefficients of variation for total and unconjugated plasma oestriol of 15.0% and 16.5% respectively. They attributed the different results for unconjugated plasma oestriol to the use of a less specific antiserum in their earlier work.
Another approach was to compare the different plasma oestriol fractions with matched 24hour urinary oestriol assays from the same subject, on the assumption that the plasma fraction which correlated most closely with the total urinary oestriol was likely to be the best. The coefficients of correlation between 24-hour urinary oestriol and plasma conjugated oestriol was 0.68, compared with the coefficient of correlation of 0.59 for urinary oestriol and plasma free oestriol (Klopper et al. 1975) . Clinical studies on serial plasma oestriol assays in pregnancies complicated by pre-eclampsia showed that the curve drawn through the mean values in late pregnancy was significantly lower than the corresponding curve for normal pregnancy, but there was no analysis of the predictive value in relation to fetal outcome (Masson 1973a) .
A similar study comparing mean oestriol plasma levels in late pregnancy complicated by fetal growth retardation with those in normal pregnancy showed a progressive fall in the abnormal group in contrast to the normal (Masson 1973b) . Although all 8 cases with abnormal plasma oestriol levels delivered low-birth-weight babies, there were 10 patients who had normal serial plasma oestriol profiles of whom 5 delivered low-birth-weight babies. The numbers of cases in this study were too small to evaluate the prognostic significance of the test. Klopper et al. (1976) compared mean plasma oestriol values in normal pregnancies with those from growth-retarded normotensive and growth-retarded hypertensive groups; the means in the two abnormal groups were significantly lower than the mean in the control group, but no analysis of predictive value was presented.
At present, the value of plasma oestriol for predicting fetal outcome remains uncertain, and further clinical studies are necessary. However, Klopper (1976) drew attention to the fact that oestriol is distributed not only in the maternal plasma, but also in the maternal enterohepatic circulation, the intervillous space, the fetal circulation, and the liquor amnii. Moreover, there is little evidence of equilibrium between these compartments, so that measurements which try to assay the production rate of oestriol by the fetoplacental unit are more likely to be useful than measurements of oestriol concentration in a particular compartment.
Human placental lactogen Human placental lactogen (HPL) or chorionic somatomarnmotrophin is a protein hormone of placental origin which is measured in the maternal serum by radioimmunoassay and which has been extensively reported as a placental function test. Seppala & Ruoslahti (1970) found a significant correlation between serum HPLjust before labour and the birth weight of the baby, but no correlation between abnormally low HPL and fetal distress in labour. Teoh et al. (1971) showed that in pregnancies complicated by hypertension, a serum HPL of less than 4 Ilg/ml was associated with an incidence of 24% intrauterine deaths in mild hypertension, and with 48% of intrauterine deaths in severe hypertension. Several workers have reported that when HPL levels are abnormally low there is an increased incidence of dysmature babies, the range in different papers being 55-71 % (Spellacy et al. 1976 , England et al. 1974 , Lindberg & Nilsson 1973 , Hensleigh et al. 1978 . A persistently low serum HPL has also been shown to be associated with an increased incidence of fetal distress in labour, ranging from 43% (England et al. 1974 ) to 71% (Letchworth & Chard 1972 . In other papers where abnormal fetal outcome was defined as either dysmaturity, fetal distress or neonatal asphyxia, low serum HPL levels in pregnancy were reported as being associated with an increased incidence of abnormal fetal outcome ranging from 27% to 43%, and with less than 10% of false positives (Kelly et al. 1975 , Garoff & Seppala 1976 , Josimovich et al. 1977 .
These results suggest that the predictive value of serial serum HPL assays for fetal distress in labour is only moderately good, with incidences of false positives in different papers which vary from 29% to 57%. In this respect the value of HPL assays seems comparable with that of 24hour urinary oestriol assays. The predictive value of serial serum HPL assays for dysmaturity is in the range 55-71 %, which compares un favourably with that of serial 24-hour urinary oestriol assays.
Placental enzymes
The placenta is rich in enzymes and this is reflected in the increasing concentrations of some of these enzymes, notably the placental isoenzyme of alkaline phosphates and oxytocinase, in the maternal plasma as pregnancy advances. There is a considerable literature which has been reviewed quite recently (Curzen 1976 ), on the possible role of maternal serum enzyme assays in the evaluation of fetoplacental function. There appears to be general agreement that with the exception of placental alkaline phosphatase and oxytocinase, serial enzyme assays have no value for predicting fetal outcome. In the case of these two enzymes there are conflicting reports of their prognostic value, depending upon the method used for assessing serial assay results. Most papers have used visual assessment of the profiles obtained by charting serial results, which have been interpreted as normal if they were rising, or abnormal if they were falling: Those workers who derived linear discriminant functions from serial assay results, in order to distinguish normal from abnormal, concluded that these enzymes were of prognostic value (Petrucco et ai. 1973 , Chapman et ai. 1976 .
Ultrasound measurements
The introduction of diagnostic ultrasound into obstetric practice during the past decade has provided a safe means of studying the fetus in utero more directly than had been possible before, and has enabled serial measurements of the biparietal diameter to be made in order to determine the growth rate of the fetal skull (Willocks et ai. 1967) . Refinements in ultrasonic measuring techniques made it possible to use serial cephalometry for diagnosing intrauterine growth retardation and accurately predicting the birth of dysmature babies in 82% of cases (Campbell & Dewhurst 1971) . More recently sonar measurements of the fetal abdominal circumference have enabled accurate prediction of the birth weight to be made with errors of less than 145 grams in 94% of cases (Higginbottom et al. 1975) , while a single measurement at 32 weeks correctedly predicted 87% of babies with birth weights below the 5th percentile (Campbell & Wilkin 1975) . The recent introduction of ultrasound measurement of the fetal head-to-abdomen circumference may prove a further refinement in the early assessment of fetal growth retardation, since there is evidence that growth retardation of the trunk precedes that of the skull (Campbell & Thoms 1977) .
Cardiotocography and other fetal measurements
The simultaneous recording of the instant fetal heart rate and the uterine contraction pattern by cardiotocography is now widely used to monitor the fetal condition in labour, and for the early detection of fetal hypoxia. Cardiotocography has also been successfully used in late pregnancy to detect those fetuses which are likely to become hypoxic during labour. This depends on analysing the beat-to-beat variations in the baseline fetal heart rate, any accelerations which may occur at the time of fetal movements, and any decelerations which may occur in relation to uterine contractions. The spontaneously occurring Braxton Hicks' contractions are used in the unstressed form of the test, and the oxytocin challenge test uses a carefully titrated intravenous injection of Syntocinon in order to stimulate contractions which mimic those of normal labour. In different papers reporting results with the oxytocin challenge test the correct prediction rate for fetal distress in labour has varied from 70% to 86%, with a range of false negatives from 5% to 32% (Hayden et ai. 1975 , Weingold et al. 1975 , Bhakthavathsalan et al. 1976 , Schulman et al. 1977 , Braly & Freeman 1978 . Unstressed cardiotocography has been reported as correctly predicting fetal distress in 65% with positive tests, and with only 2% false negatives (Visser & Huisjes 1977) . It has recently been shown that the fetal heart rate accelerates in response to acoustic stimuli (Read & Miller 1978) , and this may also form the basis of a method for assessing fetal condition in future. The study of fetal breathing movements in utero using diagnostic ultrasound (Boddy & Mantell 1973 ) provides a further technique for studying fetal function which might have clinical applications. The simple recording of fetal movements by the mother keeping a 'kick chart' has already been shown to have prognostic value (Pearson & Weaver 1976) . It seems probable that in future there will be greater reliance on direct biophysical and dynamic tests of fetal function during pregnancy, with a corresponding reduction in the importance attached to the more indirect biochemical tests.
